We need to partner up if the LC results are good. No point sitting on good data, and we certainly arent going to trial with LC alone.
so.. what is the point of good potential here outside further proving our drug is platform and ANP awareness?I assume we are in discussions with potential partners who can buddy up with us to make the data worthwhile. It would be nice if this was to be announced together with the data result ann... if so could explain an extra fortnight of silence.
i dont think MD would write "shortly" in bold if the results are bad or average. To me... the longer (within reason) this LC ann takes the better. SP could go above everyones expectations, if the ann has some meat to it.
For General Information, page-1070
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.41M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.6¢ | $148.9K | 1.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 48919 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 70000 | 1 |
View Market Depth
| Last trade - 15.59pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.8¢ |
Change
0.000 ( 2.63 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.7¢ | 43057 | ||
| Last updated 13.04pm 03/05/2024 ? | |||||
| PER (ASX) Chart |